Team:Freiburg/Highlights/2
From 2013.igem.org
(Difference between revisions)
Line 250: | Line 250: | ||
<li> | <li> | ||
<div class="frontpage-slide"> | <div class="frontpage-slide"> | ||
- | + | <p id="h1"> | |
- | + | HIGHLIGHTS | |
- | + | </p> | |
- | + | <br> | |
- | + | ||
- | + | <div id="preample"> | |
- | + | <p id="h4"><font size="5"><i style="margin-left:95px;">In the last months we were able to ...</i></font></p> | |
- | + | ||
+ | <ul style="font-size:18px; margin-left:110px;"> | ||
+ | |||
+ | <li> ... construct a catalytically inactive version of <b>Cas9</b> and thus generate a <b>DNA binding protein</b>.</li> | ||
+ | <li> ... combine this modified dCas9 with different transcriptional <b>effectors</b>.</li> | ||
+ | <li> ... express this fusion proteins in various <b>mammalian</b> cell lines.</li> | ||
+ | <li> ... <b>control</b> mammalian gene expression via our modified CRISPR/Cas fusion proteins.</li> | ||
+ | <li> ... build devices for controling gene expression by <b>light stimulus</b>.</li> | ||
+ | <li> ... provide an RNA plasmid for easily inserting sequences for crRNAs which target every desired target.</li> | ||
+ | <li> ... build an online tool that generates customized <b>manuals</b> for using our toolkit</li> | ||
+ | <li> ... develop a method to assess the <b>DNA binding capacity</b> of our dCas9-fusion proteins.</li> | ||
+ | <li>... make our dCas9 <b>accessible</b> to the whole iGEM community by mutating illegal iGEM restriction sites</b>.</li> | ||
+ | <li><i> ... In summary, we can now offer a universally applicable <b>toolkit</b> for gene regulation.</i></li> | ||
+ | </ul> | ||
+ | |||
+ | |||
+ | |||
+ | </div> | ||
+ | |||
</div> | </div> | ||
<div class=clear></div> | <div class=clear></div> |
Revision as of 10:37, 4 October 2013